Picture of I Sens logo

099190 I Sens Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Momentum

Relative Strength (%)
1m-23.15%
3m-10.33%
6m-32.37%
1yr+35.02%
Volume Change (%)
10d/3m-13.14%
Price vs... (%)
52w High-43.95%
50d MA-12.88%
200d MA-11.01%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)27.05
PEG Ratio (f)0.61
EPS Growth (f)80.6%
Dividend Yield (f)0.8%
Valuation (ttm)IndustryMarket
Price to Book Value2.12
Price to Tang. Book2.45
Price to Free Cashflown/a
Price to Sales2.39
EV to EBITDA35.98

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital1.69%
Return on Equity1.67%
Operating Margin2.66%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total RevenueKR₩m172,996.58189,844.26203,707.64232,934.79264,837.13269,033323,83311.03%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+50.17+1.39-12.17+36.26-51.77-6.51+80.6n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of I Sens EPS forecast chart

Profile Summary

i-SENS, Inc. is a Korea-based company mainly engaged in the manufacture and sale of biosensors. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The Company distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
May 4th, 2000
Public Since
January 30th, 2013
No. of Employees
514
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KOSDAQ
Shares in Issue
27,508,496
Blurred out image of a map
Address
i-Sens Bldg., SEOUL, 06646
Web
https://i-sens.co.kr/
Phone
+82 29166191
Auditors
Samil PricewaterhouseCoopers

099190 Share Price Performance

Upcoming Events for 099190

I Sens Inc Annual Shareholders Meeting

Q1 2024 I Sens Inc Earnings Release

Q2 2024 I Sens Inc Earnings Release

Similar to 099190

Picture of Access Bio logo

Access Bio

kr flag iconKorea Exchange - KOSDAQ

Picture of Aligned Genetics logo

Aligned Genetics

kr flag iconKorea Exchange - KOSDAQ

Picture of Asta Co logo

Asta Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Biodyne Co logo

Biodyne Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Bistos Co logo

Bistos Co

kr flag iconKorea Exchange - KOSDAQ

FAQ